Concepedia

Pierluigi Tricoci

PT

Statistics

Publications

75

Citations

11.1K

H-Index

37

Active since

2003

Affiliations

Clinical Research Institute(Current)

Stanford University

University of Alberta

Auckland City Hospital

Brigham and Women's Hospital

Pierluigi Tricoci is an author at Clinical Research Institute specializing in cardiology, medicine, and acute coronary syndromes.

Publications per year

2003–2024

75

Publications

75

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text

, , +17

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

, , +17

Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines

Pierluigi Tricoci · JAMA · 2009 · 917 citations

, , +9

Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

Pierluigi Tricoci, Zhen Huang, Claes Held et al. · New England Journal of Medicine · 2011 · 753 citations · Full text

, , +16

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

Gregory G. Schwartz, Laurence Bessac, Lisa G. Berdan et al. · American Heart Journal · 2014 · 411 citations · Full text

, , +17

1–5 of 75